Curis (CRIS) EPS (Weighted Average and Diluted) (2010 - 2026)
Curis (CRIS) reported EPS (Weighted Average and Diluted) of -$1.25 for Q1 2026, little changed on a YoY basis from -$1.25 in Q1 2025, and down 177.64% quarter-over-quarter from $1.61 in Q4 2025.
Curis (CRIS) EPS (Weighted Average and Diluted) (2010 - 2026) Analysis & Trends
Curis has reported EPS (Weighted Average and Diluted) for 12 years, with the latest figure at -$1.25 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) changed 0.0% year-over-year to -$1.25; the trailing twelve-month figure through Mar 2026 stood at -$0.81 (up 86.7% YoY), and the FY2025 full-year result was -$0.58, up 91.57% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$1.25, down from $1.61 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $1.61 in Q4 2025, with the low at -$2.83 in Q3 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$1.38 across 5 years, with a median of -$1.7 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Weighted Average and Diluted) tumbled 2258.33% — and 2025, when it surged 245.05%.
- Curis' EPS (Weighted Average and Diluted) stood at -$2.32 in 2022, then rose by 13.79% to -$2.0 in 2023, then surged by 44.5% to -$1.11 in 2024, then surged by 245.05% to $1.61 in 2025, then sank by 177.64% to -$1.25 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$1.25 (Q1 2026), $1.61 (Q4 2025), and -$0.49 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 0.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -0.61 |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | -1.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.25 |
| Dec 31, 2025 | 1.61 |
| Sep 30, 2025 | -0.49 |
| Jun 30, 2025 | -0.68 |
| Mar 31, 2025 | -1.25 |
| Dec 31, 2024 | -1.11 |
| Sep 30, 2024 | -1.70 |
| Jun 30, 2024 | -2.03 |
| Mar 31, 2024 | -2.05 |
| Dec 31, 2023 | -2.00 |
| Sep 30, 2023 | -2.13 |
| Jun 30, 2023 | -2.47 |
| Mar 31, 2023 | -2.39 |
| Dec 31, 2022 | -2.32 |
| Sep 30, 2022 | -2.83 |
| Jun 30, 2022 | -0.17 |
| Mar 31, 2022 | -0.18 |
| Dec 31, 2021 | 0.85 |
| Sep 30, 2021 | -0.12 |
| Jun 30, 2021 | -0.12 |